Archives
-
ML216: A BLM Helicase Assay-to-Mechanism Guide
2026-08-18
ML216 is a BLM helicase inhibitor that connects DNA unwinding assays with mechanistic cancer biology. This guide distinguishes BLM-directed evidence from WRN-centered synthetic-lethality findings and provides a rigorous framework for biochemical, cellular, and translational experiments.
-
Adipose–Neural Axis in Cardiac Arrhythmias
2026-08-18
Fan et al. developed a stem cell-based coculture model showing how epicardial adipose tissue can communicate with sympathetic neurons and cardiomyocytes through a leptin–NPY pathway. The study identifies Y1R, NCX, and CaMKII as mechanistic points associated with arrhythmogenesis and supports the relevance of this axis by analyzing epicardial adipose tissue and coronary sinus blood from patients with atrial fibrillation.
-
HBTU Peptide Synthesis: Reliable Workflows
2026-08-17
This scenario-based guide explains how HBTU (2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate), SKU A7023, can improve the reproducibility of peptide test articles used in cell viability and cytotoxicity studies. It separates documented reagent properties from peptide-level biological evidence and provides practical guidance on compatibility, storage, optimization, interpretation, and vendor selection.
-
Triacetin Digestion and Hepatic Metabolic Signaling
2026-08-17
This rat study clarifies how the short-chain triacylglycerol triacetin is digested, absorbed, and linked to hepatic metabolic regulation. Its central finding is that triacetin is degraded in the upper gastrointestinal tract into acetate and glycerol, which may act both as metabolic substrates and as signals influencing hepatic AMPK activity and lipid-related gene expression.
-
RSV NS3 Hijacks Host Signaling to Balance Pathogenicity
2026-08-16
Zhuang et al. show that Rice stripe virus NS3 uses phosphorylation and stage-dependent interactions with the OsSnRK3.25–OsCBL1/3–OsRBOHF pathway to coordinate antiviral defense, pathogenicity, and transmission. The study provides a mechanistic model for virus–plant–vector co-survival and offers a useful framework for analyzing how pathogens tune host signaling rather than simply suppressing it.
-
ORM2, ZG16, and Autophagy in Pancreatic Fibrosis
2026-08-15
A 2026 Pancreatology study identifies ORM2 as an endogenous suppressor of chronic pancreatitis-associated fibrosis, acting through ZG16 to limit autophagy-driven pancreatic stellate cell activation. Its combination of pancreas-specific gene manipulation, flux assays, and interaction studies provides a mechanistic framework for evaluating ORM2–ZG16 signaling in preclinical pancreatic fibrosis research.
-
PFHxS Hepatotoxicity Through PPARα in Zebrafish
2026-08-14
This study combines transcriptomics, liver pathology, biochemical measurements, targeted gene analysis, pharmacological antagonism, and PPARα morpholino knockdown to investigate PFHxS toxicity in larval zebrafish. Its findings link environmentally relevant PFHxS exposure with steatosis, necrosis, impaired liver function, and PPAR-associated molecular disruption, while also showing that pathway intervention can lessen several toxicological endpoints.
-
N-MYC/eIF4G1 Axis in inv(16) AML
2026-08-14
Peramangalam et al. identify a previously unrecognized MYCN enhancer and show that N-MYC supports inv(16) acute myeloid leukemia survival through the translation-initiation factor eIF4G1. By combining transcriptomic analysis, enhancer investigation, cellular perturbation, primary leukemia models, and xenografts, the study defines a mechanistic survival axis downstream of CBFβ-SMMHC-associated transcriptional disruption.
-
ALDOB K87 Lactylation in Pulmonary Hypertension
2026-08-13
The reference study identifies ALDOB lysine-87 lactylation as a metabolic control point linking hypoxia-driven glycolysis to DRP1-dependent mitochondrial fission in pulmonary hypertension. By combining lactylomic profiling, human pulmonary artery smooth muscle cell experiments, and rodent validation, the authors connect lactate accumulation with pathological vascular-cell behavior and define the SIRT1–ALDOB–DRP1 axis as a potential research target.
-
Bestatin and Endothelial Invasion in Fibrin Matrices
2026-08-13
The reference study showed that bestatin, an aminopeptidase inhibitor previously associated with anti-angiogenic activity, dose-dependently increased microvascular endothelial cell invasion and capillary-like tube formation in a fibrin matrix. Its results challenge the assumption that bestatin acts uniformly through CD13 inhibition and demonstrate why matrix composition, protease activity, and matrix integrity must be considered when interpreting angiogenesis assays.
-
Cdk1–PP2A Switch Controls Atypical E2F Degradation
2026-08-12
This preprint identifies a phosphorylation-dependent molecular switch that couples Cdk1, PP2A, and APC/C activity to the orderly degradation of E2F7 and E2F8 during mitotic exit. By combining cell-based and cell-free systems, the study shows how dephosphorylation in G1 helps release E2F1-driven transcriptional activity and clarifies how phosphorylation can regulate the timing of ubiquitin-mediated substrate destruction.
-
CTCF–FLG-AS1 Control of PDAC Progression
2026-08-12
This study identifies a multilayered mechanism in which CTCF drives pancreatic ductal adenocarcinoma through FLG-AS1-dependent chromatin regulation, IGF2BP2 activity, CSF1 signaling, and macrophage polarization. Its main significance is the connection of tumor-intrinsic epigenetic and RNA-regulatory events with a tumor-associated macrophage response, providing a mechanistic framework for preclinical immunotherapy research.
-
BKT140 CXCR4 Antagonist Workflow Guide
2026-08-11
A scenario-based guide to using BKT140 (BL-8040, TF 14016) CXCR4 Antagonist, SKU B7833, in viability, chemotaxis, apoptosis, and hematopoietic stem cell mobilization assays. It connects CXCR4 biology with practical controls, formulation choices, interpretation safeguards, and vendor-selection criteria.
-
Fenofibrate, Aging, and PPARα-YAP Liver Growth
2026-08-11
The reference study shows that Fenofibrate induces comparable liver enlargement and PPARα-YAP pathway activation in adult and aging mice. By combining chemically induced, naturally aged, and senescence-accelerated models, it suggests that aging does not substantially blunt the hepatic hypertrophic or proliferative response to this PPARα agonist.
-
SHH, FGF10, and Species-Specific Penile Development
2026-08-10
A 2025 comparative study shows that differences in Shh, Fgf10, and Fgfr2 expression help explain why mice form a tubular urethra without a prominent open groove, whereas guinea pigs form a transiently open urethral groove and develop the prepuce later. By combining developmental expression mapping with ex vivo pathway perturbation, the study connects species-specific gene regulation to penile morphogenesis and provides a more appropriate framework for interpreting human developmental biology.